SMTL ID : 5dt2.1 (1 other biounit)

Crystal structure of Dot1L in complex with inhibitor CPD11 [N4-methyl-N2-(2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl)pyrimidine-2,4-diamine]

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

monomer

Ligands

1 x 5EV: N~4~-methyl-N~2~-[2-methyl-1-(2-phenoxyphenyl)-1H-indol-6-yl]pyrimidine-2,4-diamine(Non-covalent)

5EV.1: 18 residues within 4Å: Chain A: F.132, S.141, L.144, V.145, M.148, D.162, G.164, S.165, V.170, F.240, V.241, N.242, F.244, V.268, S.269, S.270, S.312, Y.313 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:F.132, A:F.132, A:L.144, A:V.145, A:F.240, A:F.244, A:F.244, A:Y.313 Hydrogen bonds: A:D.162, A:N.242 Water bridges: A:F.132, A:G.168, A:N.242 pi-Stacking: A:F.132

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: T.101, R.102, K.213 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.102 Salt bridges: A:R.102, A:K.213 SO4.3: 2 residues within 4Å: Chain A: N.80, R.81 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.80 Salt bridges: A:R.81

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, C. et al., Discovery of Novel Dot1L Inhibitors through a Structure-Based Fragmentation Approach. Acs Med.Chem.Lett. (2016)

Release Date

2016-06-15

Peptides

Histone-lysine N-methyltransferase, H3 lysine-79 specific: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Histone-lysine N-methyltransferase, H3 lysine-79 specific

Related Entries With Identical Sequence